188 related articles for article (PubMed ID: 20942599)
1. Valproic acid and all trans retinoic acid differentially induce megakaryopoiesis and platelet-like particle formation from the megakaryoblastic cell line MEG-01.
Schweinfurth N; Hohmann S; Deuschle M; Lederbogen F; Schloss P
Platelets; 2010; 21(8):648-57. PubMed ID: 20942599
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of neuronal dopamine and serotonin transporters DAT and SERT in megakaryocytes and platelets generated from human MEG-01 megakaryoblasts.
Hohmann S; Schweinfurth N; Lau T; Deuschle M; Lederbogen F; Banaschewski T; Schloss P
Cell Tissue Res; 2011 Nov; 346(2):151-61. PubMed ID: 22006250
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic drugs inhibit in vitro megakaryopoiesis via the alpha7-nicotinic acetylcholine receptor.
Thornton S; Schedel A; Besenfelder S; Klüter H; Bugert P
Platelets; 2011; 22(5):390-5. PubMed ID: 21385097
[TBL] [Abstract][Full Text] [Related]
4. A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis.
Liu B; Ohishi K; Yamamura K; Suzuki K; Monma F; Ino K; Nishii K; Masuya M; Sekine T; Heike Y; Takaue Y; Katayama N
Exp Hematol; 2010 Aug; 38(8):685-95. PubMed ID: 20381581
[TBL] [Abstract][Full Text] [Related]
5. The Hippo pathway regulates human megakaryocytic differentiation.
Lorthongpanich C; Jiamvoraphong N; Supraditaporn K; Klaihmon P; U-Pratya Y; Issaragrisil S
Thromb Haemost; 2017 Jan; 117(1):116-126. PubMed ID: 27786336
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers.
Vulcano F; Ciccarelli C; Mattia G; Marampon F; Giampiero M; Milazzo L; Pascuccio M; Zani BM; Giampaolo A; Hassan HJ
Exp Cell Res; 2006 May; 312(9):1590-7. PubMed ID: 16739251
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells.
Wu Y; Guo SW
Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):198-203. PubMed ID: 17376583
[TBL] [Abstract][Full Text] [Related]
8. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid regulates erythro-megakaryocytic differentiation through the modulation of transcription factors and microRNA regulatory micro-networks.
Trécul A; Morceau F; Gaigneaux A; Schnekenburger M; Dicato M; Diederich M
Biochem Pharmacol; 2014 Nov; 92(2):299-311. PubMed ID: 25241289
[TBL] [Abstract][Full Text] [Related]
10. Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia.
Cimino G; Lo-Coco F; Fenu S; Travaglini L; Finolezzi E; Mancini M; Nanni M; Careddu A; Fazi F; Padula F; Fiorini R; Spiriti MA; Petti MC; Venditti A; Amadori S; Mandelli F; Pelicci PG; Nervi C
Cancer Res; 2006 Sep; 66(17):8903-11. PubMed ID: 16951208
[TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
Qi H; Ratnam M
Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
[TBL] [Abstract][Full Text] [Related]
13. In vitro characteristics of valproic acid and all-trans-retinoic acid and their combined use in promoting neuronal differentiation while suppressing astrocytic differentiation in neural stem cells.
Chu T; Zhou H; Wang T; Lu L; Li F; Liu B; Kong X; Feng S
Brain Res; 2015 Jan; 1596():31-47. PubMed ID: 25463022
[TBL] [Abstract][Full Text] [Related]
14. Production of functional platelet-like particles by the megakaryoblastic DAMI cell line provides a model for platelet biogenesis.
Lev PR; Goette NP; Glembotsky AC; Laguens RP; Meckert PM; Salim JP; Heller PG; Pozner RG; Marta RF; Molinas FC
Platelets; 2011; 22(1):28-38. PubMed ID: 21143024
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells.
Lazzari L; Henschler R; Lecchi L; Rebulla P; Mertelsmann R; Sirchia G
Haematologica; 2000 Jan; 85(1):25-30. PubMed ID: 10629587
[TBL] [Abstract][Full Text] [Related]
16. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
Cheng L; Qasba P; Vanguri P; Thiede MA
J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
[TBL] [Abstract][Full Text] [Related]
17. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
18. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia.
Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N
Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213
[TBL] [Abstract][Full Text] [Related]
19. Regulation of differentiation of MEG01 to megakaryocytes and platelet-like particles by Valproic acid through Notch3 mediated actin polymerization.
Dhenge A; Kuhikar R; Kale V; Limaye L
Platelets; 2019; 30(6):780-795. PubMed ID: 30332548
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid for the treatment of myeloid malignancies.
Kuendgen A; Gattermann N
Cancer; 2007 Sep; 110(5):943-54. PubMed ID: 17647267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
